Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05117177
Title New Formulation Study of Inupadenant (EOS100850) in Patients With Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors iTeos Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | BEL


No variant requirements are available.